IL6 and Alzheimer disease: A significant decrease in IL‐1β (20%, Figure 3C‐3), IL‐6 (19%, Figure 3D), tumor necrosis factor‐α (TNF‐α, 37%, Figure 3E), and α1‐antichymotrypsin (α1‐ACT: 25%, Figure 3F) in AD brains was also observed following treatment with Ab‐TP‐MDNPs as measured by ELISA in whole brain homogenates.